Literature DB >> 7057359

Liposome disposition in vivo II: Dose dependency.

M E Bosworth, C A Hunt.   

Abstract

The dose-dependent disposition of extruded multilamellar (diameter approximately 1 micrometer) negatively charged liposomes containing entrapped [14C]inulin was studied in mice. Mice received 1500, 300, or 15 mumoles of liposomal lipid/kg iv. Carbon 14 levels were measured in the blood, liver, spleen, and carcass for 72 hr. A pronounced saturation effect, consistent with the known dose behavior of other colloids, was seen at early times; it was manifested by higher dose values in the blood and spleen but by lower liver values as the dose increased. This dose effect was attenuated in the liver but was maintained in the spleen at later times, and percent dose values approached plateau values in all tissues for all doses at later times. [14C]Inulin was used at the liposomal marker because of its inability to enter cells (or, presumably, leave them if delivered there by liposomes) in its free form. An early decline in carbon 14 levels (over the first 48 hr) was seen in the liver for the low and medium doses. Because of the known ability of blood factors to cause liposomes to leak their contents, this decline was interpreted as being a loss of [14C]inulin from extracellularly bound liposomes during this period. Moreover, the plateau carbon 14 levels at later times were interpreted as approximating the true level of intracellular inulin delivery by the liposomes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057359     DOI: 10.1002/jps.2600710124

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.

Authors:  H Sakai; H Horinouchi; K Tomiyama; E Ikeda; S Takeoka; K Kobayashi; E Tsuchida
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

3.  Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

Authors:  H Harashima; C Yamane; Y Kume; H Kiwada
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

4.  Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin.

Authors:  J A Balazsovits; L D Mayer; M B Bally; P R Cullis; M McDonell; R S Ginsberg; R E Falk
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.

Authors:  L D Mayer; R Nayar; R L Thies; N L Boman; P R Cullis; M B Bally
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.

Authors:  Y Sadzuka; S Hirotsu; S Hirota
Journal:  Jpn J Cancer Res       Date:  1999-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.